Ever since its foundation, VisMederi has focused much of its attention on developing serological testing required for the registration of both seasonal and pandemic influenza vaccines on behalf of regulatory agencies such as the EMA, FDA and PMDA.

Read more

Quality is an important value for VisMederi. It is the core of a trust-based relationship with clients, partners and employees and is an integral part of business culture. VisMederi conducts all of its activities in compliance with the European system of certification UNI EN ISO 9001:2015

Read more

VisMederi provides a vast portfolio of services which include the development of virological and serological testing, diagnostic testing used for the evaluation of the efficacy of new drugs, cell culture services and project management principally for clinical trials.

Read more